U.S. Accuses CVS of Defrauding Medicare over Prescriptions
E6011 & Tocilizumab Monotherapy Studies Show Promising Results for RA Patients
Rheumatology Drug Updates: Opana ER Painkiller Pulled from U.S. Market; Upadacitinib to Treat RA, and More
Brodalumab Approved for Plaque Psoriasis, Plus Baricitinib Effiicacy Studied for RA
Biosimilar Drugs Raise Questions around Treatment Efficacy, Quality, Safety
Would Legalizing Medical Marijuana Help Curb the Opioid Epidemic?
Prescription-Drug Monitoring Cuts Doctor-Shopping for Painkillers
Tips, Resources to Help Rheumatologists Educate Patients on Biologics and Biosimilars
OIG Releases 2017 Work Plan: A Summary
- 1
- 2
- 3
- …
- 10
- Next Page »